CrossLife Technologies Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1000K

  • Investors
  • 5

CrossLife Technologies General Information

Description

Developer of molecular diagnostics technologies designed to detect infectious and non-communicable diseases. The company's molecular diagnostics technologies are based on nucleic acid and DNA and it develops technologies into pathogen detection tests for many infectious diseases including HIV, malaria, chikungunya, and flu, enabling doctors to detect infectious pathogens directly from diverse sample types without sample preparation, polymerase chain reaction or instrumentation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 5937 Darwin Court
  • Suite 105
  • Carlsbad, CA 92008
  • United States
+1 (760) 000-0000
Primary Industry
Medical Supplies
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Corporate Office
  • 5937 Darwin Court
  • Suite 105
  • Carlsbad, CA 92008
  • United States
+1 (760) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CrossLife Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 15-Jan-2021 $1000K Completed Startup
8. Grant 15-Sep-2019 00000 Completed Startup
7. Grant 12-Sep-2019 00000 Completed Startup
6. Grant 15-Mar-2019 000000 Completed Startup
5. Grant 01-Jan-2018 00000 Completed Startup
4. Grant 01-Jan-2017 00000 Completed Startup
3. Grant 01-Jul-2016 00000 Completed Startup
2. Grant 10-Mar-2016 $2.43M Completed Startup
1. Accelerator/Incubator Completed Startup
To view CrossLife Technologies’s complete valuation and funding history, request access »

CrossLife Technologies Patents

CrossLife Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210139958-A1 Engineered gyri-like mutein aptamers, and related methods Pending 13-Nov-2019 0000000000
EP-4058580-A1 Engineered gyri-like mutein aptamers, and related methods Pending 13-Nov-2019 0000000000
EP-4058580-A4 Engineered gyri-like mutein aptamers, and related methods Pending 13-Nov-2019 000000000 0
US-20200354800-A1 Rapid nucleic acid detection without sample preparation Active 08-May-2019 0000000000
US-11685960-B2 Rapid nucleic acid detection without sample preparation Active 08-May-2019 C12Q1/701 0
To view CrossLife Technologies’s complete patent history, request access »

CrossLife Technologies Executive Team (1)

Name Title Board Seat
Hyundae Cho Ph.D Founder, President, Chief Executive Officer & Board Member
To view CrossLife Technologies’s complete executive team members history, request access »

CrossLife Technologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Science Foundation Government 000 0000 000000 0
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Bio, Tech and Beyond Accelerator/Incubator 000 0000 000000 0
To view CrossLife Technologies’s complete investors history, request access »

CrossLife Technologies FAQs

  • When was CrossLife Technologies founded?

    CrossLife Technologies was founded in 2010.

  • Who is the founder of CrossLife Technologies?

    Hyundae Cho Ph.D is the founder of CrossLife Technologies.

  • Who is the CEO of CrossLife Technologies?

    Hyundae Cho Ph.D is the CEO of CrossLife Technologies.

  • Where is CrossLife Technologies headquartered?

    CrossLife Technologies is headquartered in Carlsbad, CA.

  • What industry is CrossLife Technologies in?

    CrossLife Technologies’s primary industry is Medical Supplies.

  • Is CrossLife Technologies a private or public company?

    CrossLife Technologies is a Private company.

  • What is CrossLife Technologies’s current revenue?

    The current revenue for CrossLife Technologies is 000000.

  • Who are CrossLife Technologies’s investors?

    National Science Foundation, National Institute for Allergy and Infectious Disease, National Institutes of Health, U.S. Department of Health and Human Services, and Bio, Tech and Beyond have invested in CrossLife Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »